txa127
Showing 1 - 8 of 8
Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)
Terminated
- Lymphoma, Non-Hodgkin
- +2 more
- TXA127
- Placebo
-
Duarte, California
- +9 more
Dec 7, 2020
COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)
Recruiting
- COVID-19
- +2 more
- TXA127
- +3 more
-
Birmingham, Alabama
- +68 more
Jan 24, 2023
Miscellaneous Peripheral Blood Cell Abnormalities Trial in Tacoma (TXA127, Neupogen (filgrastim))
Completed
- Miscellaneous Peripheral Blood Cell Abnormalities
- TXA127
- Neupogen (filgrastim)
-
Tacoma, WashingtonCharles River Clinical Servies Norhtwest
Aug 29, 2016
Hematologic Malignancies Trial in Charlottesville (TXA127)
Withdrawn
- Hematologic Malignancies
- TXA127
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Aug 29, 2016
Myelodysplastic Syndrome (MDS) Trial in Houston (TXA127)
Terminated
- Myelodysplastic Syndrome (MDS)
- TXA127
-
Houston, TexasMD Anderson Leukemia Department
Aug 29, 2016
Hematologic Malignancies Trial in Atlanta, St Louis (TXA127)
Withdrawn
- Hematologic Malignancies
- TXA127
-
Atlanta, Georgia
- +1 more
Aug 29, 2016
Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease Trial in Durham (TXA127)
Withdrawn
- Cord Blood Transplant
- +2 more
- TXA127
-
Durham, North CarolinaPediatric Bone and Cord Blood, Duke Univ. Med. Center
Aug 29, 2016